UK to finance 'world first' AI biosecurity lab and boost AI security funding in prebudget package

LONDON, October 24, 2026. Chancellor of the Exchequer John Healey on Saturday set out a high profile prebudget technology package that will direct public money and industry resources into a new national AI Biosecurity Laboratory and a series of related AI and cyber security initiatives. The announcements, which are due to be formalised in the Autumn Budget on October 28, mark a striking effort by the government to tie industrial strategy to national security while courting inward support from major AI developers.

What the package includes

The measures announced over the weekend include a government commitment of about 100 million pounds to establish an AI Biosecurity Lab, described by ministers as a ‘‘world first’’ facility to use advanced AI to detect biological threats and accelerate development of medical countermeasures. Ministers said the lab will be backed by substantial in kind support from private AI firms, with OpenAI and Anthropic reported to provide up to 200 million pounds in model credits to power research and operational work inside the new facility.

Alongside the biosecurity lab the package adds roughly 120 million pounds to the UK AI Security Institute, the state backed technical body that evaluates risks from advanced models. The government also plans further investments, including funding for a National Exposure and Real Time Vulnerability Centre and a National Cyber Shield to use agentic AI tools for detecting and responding to cyber threats across critical infrastructure and commercial systems.

Why ministers are linking AI and biosecurity

Officials said the measures respond to two linked challenges. First, AI tools are now being used across life sciences for tasks ranging from molecule design to vulnerability discovery, which can speed medical innovation but also create potential misuse pathways. Second, recent high profile software vulnerabilities and cloud outages have highlighted the risks that software faults and hostile actors pose to public services and private markets.

By placing compute, model access and specialist facilities under a sovereign umbrella, the government argues it can both accelerate beneficial research and maintain tighter oversight of dangerous capabilities. The minister for AI described the lab as designed to bring together scientific expertise and secure compute to protect the UK economy and health system while making the country an attractive base for advanced life sciences companies.

Market and investor implications

The interventions will matter to multiple investor groups. For life sciences and biotech, easier access to large scale compute and model credits could lower R and D costs and speed time to proof of concept for AI enabled drug discovery. That could make UK based start ups more investible and support scale up activity in the Cambridge and Oxford innovation clusters.

For the cloud and AI supply chain, the plan signals government willingness to underwrite access to leading models rather than rely solely on market purchases. That reduces a key friction for smaller companies but raises questions about long term commercial models and the concentration of dependency on a small number of foreign model providers.

Financial markets will also be watching the wider Budget context. Reports accompanying the announcement suggest the Chancellor plans additional capital for state development lenders, including the British Business Bank and a National Wealth Fund, a move intended to expand scale-up finance and shore up industrial investment. Those measures could shift where private capital flows across the UK economy and alter the risk calculus for venture and growth equity managers considering UK deals.

Risks, critics and regulatory questions

Civil society groups and some opposition politicians warned the announcements look like a shopping list of projects without clearly defined governance arrangements. Critics highlighted two risks. First, heavy reliance on model credits from overseas firms could entrench foreign control over compute resources that underpin British research. Second, using advanced AI in biosecurity raises ethical and oversight questions about who controls potentially sensitive datasets and how dual use research will be governed.

Ministers say funding for the AI Security Institute and the planned NERV centre will create the technical oversight needed to manage those concerns. Investors and industry groups want more detail on procurement rules, intellectual property arrangements, and how commercial partners will be able to monetise innovations arising from the new infrastructure.

Why this matters for the UK economy

The package represents a strategic bet that the UK can convert regulatory clarity and state support into commercial advantage in AI enabled life sciences and cyber security. If implemented with transparent governance and clear commercial pathways, the lab could lower barriers for British companies to use frontier AI, accelerate high value scientific output, and attract international capital into UK clusters.

However, the outcome will depend on the Budget specifics and on whether the government can reconcile sovereign security goals with the commercial realities of model access and private sector incentives. With the formal Budget scheduled on October 28, investors and companies will be parsing the final measures closely to see whether the funding pledges translate into durable capacity for British industry and credible safeguards for national security.

Reporting from London.